Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.

Pharmaceutical

Pharvaris

Pharvaris' headquarters in Zug, Switzerland

Berndt Modig

Christa Milley

David Nassif

Leandri Heystek

Mirena Nouwen

Emily Jochim

Justin Bush

Li Zhu

Maggie Beller

Anne Lesage

Jochen Knolle

Annick Deschoolmeester

Wim Souverijns

Anna Nijdam

Peng Lu

David Meeker

Robert Glassman

Hans Schikan

Elisabeth Björk

Viviane Monges

Description

People (4)

Wim Souverijns

Anna Nijdam

Mary Burke Uhlenhopp

Giorgio Giannattasio M.D.

Jobs